University Hospital of Heidelberg, Department of Radiation Oncology
Welcome,         Profile    Billing    Logout  
 19 Trials 
23 Trials

   

Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Debus, Juergen
HIT-1, NCT01182779: Trial of Proton Versus Carbon Ion Radiation Therapy in Patients With Chordoma of the Skull Base

Recruiting
3
319
Europe
Carbon ion, Protons
Heidelberg University
Chordoma, Tumor, Treatment
08/15
08/23
METIS, NCT02831959: Pivotal, Open-label, Randomized Study of Radiosurgery with or Without Tumor Treating Fields (TTFields) for 1-10 Brain Metastases from Non-small Cell Lung Cancer (NSCLC).

Completed
3
298
Europe, Canada, US, RoW
NovoTTF-200M device, Best Standard of Care
NovoCure GmbH
Brain Metastases from Non-small Cell Lung Cancer (NSCLC)
11/24
11/24
CyberChallenge, NCT05378633: The Trial How Much is Too Much - What is the Role of Cyberknife Radiosurgery in Patients With Multiple Brain Metastases?

Recruiting
2
190
Europe
SRS, Whole Brain Radiotherapy
University Hospital Heidelberg
Brain Metastases, Nsclc
02/25
02/26
PEGASUS, NCT06408116: Predicting Esophageal Cancer Borders Using PET-Imaging

Recruiting
2
30
Europe
photon, surgical therapy, Chemotherapy
University Hospital Heidelberg
Esophagus Cancer, Stage I, Esophagus Cancer, Stage II
01/26
04/26
Radcav, NCT05871307: Neoadjuvant vs. Intraoperative vs. Adjuvant Resection Cavity Radiotherapy of Brain Metastases

Recruiting
2
90
Europe
Preoperative Radiotherapy, Intraoperative Radiation, Postoperative Radiotherapy
University Hospital Heidelberg
Brain Metastases, Radiotherapy
05/26
05/28
INDIGO, NCT05964569: Feasibility of Individualized, Model-guided Optimization of Proton Beam Treatment Planning in Patients With Low Grade Glioma

Recruiting
2
120
Europe
model-guided optimization of treatment plan, standard treatment plan, no optimization
University Hospital Heidelberg
Low Grade Glioma
11/26
11/28
ENCEPHALON, NCT03297788: Whole Brain Radiation Therapy Alone vs. Radiosurgery for SCLC Patients With 1-10 Brain Metastases

Completed
N/A
56
Europe
SRS, WBRT
Juergen Debus, Heidelberg University
SCLC, Brain Metastases
10/23
12/23
PAROS, NCT04083937: Prostate Cancer Patients Treated With Alternative Radiation Oncology Strategies

Recruiting
N/A
897
Europe
Hypofractionated radiotherapy with photons, Hypofractionated radiotherapy with protons, Normofractionated radiotherapy with photons
University Hospital Heidelberg
Prostate Cancer
04/28
01/29
NCT04613388: Registry Study of Proton Radiotherapy in Lymphoma

Recruiting
N/A
200
Europe
Assesment of Effectiveness and side effects
University Hospital Heidelberg
Mediastinal Lymphoma
08/25
08/26
PUMA, NCT05237453: Pulmonary Magnetic Resonance-guided Online Adaptive Radiotherapy of Locally Advanced Non-Small Cell Lung Cancer

Recruiting
N/A
30
Europe
Photons
University Hospital Heidelberg, University Hospital Tuebingen, Ludwig-Maximilians - University of Munich, German Cancer Research Center
Non-small Cell Lung Cancer
03/26
03/27
NAVIGATORR, NCT05671458: Multiparametric Imaging-based Intraoperative Navigation for Guidance of Surgical Resection and Postoperative Radiotherapy in Patients With Head-and-neck Tumors

Recruiting
N/A
60
Europe
intraoperative navigation and creation of tumor resection maps
Juergen Debus
Head and Neck Tumors
01/27
01/27
Paul, Angela
ENCEPHALON, NCT03297788: Whole Brain Radiation Therapy Alone vs. Radiosurgery for SCLC Patients With 1-10 Brain Metastases

Completed
N/A
56
Europe
SRS, WBRT
Juergen Debus, Heidelberg University
SCLC, Brain Metastases
10/23
12/23
Rieken, Stefan
FORTplus, NCT05045664: Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 Antibody

Recruiting
3
100
Europe
Standard, Experimental, Rituximab, Obinutuzumab
Heidelberg University
Early Stage Follicular Lymphoma WHO Grade 1/2 or 3a
12/26
12/29
RADIANCE, NCT04230759 / 2018-003005-25: Radiochemotherapy +/- Durvalumab for Locally-advanced Anal Carcinoma. a Multicenter, Randomized, Phase II Trial of the German Anal Cancer Study Group

Active, not recruiting
2
180
Europe
Chemotherapy, all brands of 5-fluorouracil (5-FU) are allowed, all brands of Mitomycin C (MMC) are allowed, Radiation, Durvalumab, PD-L1 inhibitor
Goethe University, German Cancer Aid, AstraZeneca
Anal Cancer, Anal Carcinoma, Anal Cancer Stage III, Anal Cancer Stage II
12/26
03/27
PACCELIO, NCT06102057 / 2022-003408-33: - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC

Recruiting
2
110
Europe
standard Radiotherapy, standard, Chemotherapy, Immunotherapy, Experimental Radiotherapy, Experimental
TheraOp, AstraZeneca
Stage III Non-small Cell Lung Cancer, Locally Advanced, Unresectable
06/26
06/28
ENCEPHALON, NCT03297788: Whole Brain Radiation Therapy Alone vs. Radiosurgery for SCLC Patients With 1-10 Brain Metastases

Completed
N/A
56
Europe
SRS, WBRT
Juergen Debus, Heidelberg University
SCLC, Brain Metastases
10/23
12/23
Bernhardt, Denise
NCT03697343: Fractionated Stereotactic Radiotherapy vs. Single Session Radiosurgery in Patients With Larger Brain Metastases

Recruiting
3
382
Europe
Radiosurgery, Fractionated stereotactic radiotherapy
University of Erlangen-Nürnberg Medical School
Cerebral Metastases of Solid Cancers
05/26
05/26
NCT05112549: Intrathecal Application of PD1 Antibody in Metastatic Solid Tumors With Leptomeningeal Disease (IT-PD1/ NOA 26)

Recruiting
1
46
Europe
Nivolumab [Opdivo]
University Hospital Tuebingen
Leptomeningeal Disease
09/25
09/26
NCT06146010: Non Interventional German Leptomeningeal Disease Register

Recruiting
N/A
50
Europe
No intervention
University Hospital Tuebingen
Meningeal Neoplasms, Leptomeningeal Disease
01/29
12/29
Shafie, Rami El
XRAY VISION, NCT05386550 / 2022-001144-18: Phase III Xevinapant (Debio 1143) and Radiotherapy in Resected LA SCCHN, High Risk, Cisplatin-ineligible Participants

Terminated
3
166
Europe, Canada, Japan, US, RoW
Xevinapant (Debio 1143), IMRT, Placebo
EMD Serono Research & Development Institute, Inc., Merck KGaA, Darmstadt, Germany
Head and Neck Cancer
08/24
08/24
PACCELIO, NCT06102057 / 2022-003408-33: - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC

Recruiting
2
110
Europe
standard Radiotherapy, standard, Chemotherapy, Immunotherapy, Experimental Radiotherapy, Experimental
TheraOp, AstraZeneca
Stage III Non-small Cell Lung Cancer, Locally Advanced, Unresectable
06/26
06/28
SOCOFIN-1, NCT06278831: Efficacy of Structured SOcial COnsultation and Support in Reducing the FINancial Burden of Radiotherapy

Recruiting
N/A
225
Europe
Questionnaire
University Medical Center Goettingen
Financial Toxicity
05/24
10/24
ENCEPHALON, NCT03297788: Whole Brain Radiation Therapy Alone vs. Radiosurgery for SCLC Patients With 1-10 Brain Metastases

Completed
N/A
56
Europe
SRS, WBRT
Juergen Debus, Heidelberg University
SCLC, Brain Metastases
10/23
12/23

Download Options